- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06860607
Environment and Alcohol: A Pilot Study
Background:
Alcohol use disorder (AUD) is a chronic disease that causes more than 140,000 US deaths each year. AUD treatment often includes therapy and medication. Some people with AUD may also benefit from behavioral and lifestyle changes.
Objective:
To evaluate the effects of different activities and environments on drinking behaviors and mental health in people with AUD.
Eligibility:
People aged 21 years and older with AUD.
Design:
Participants will have up to 10 study visits in Baltimore.
Participants will have a baseline visit. They will have a physical exam with blood and urine tests. They will have a breath test for alcohol and a test that measures body composition. They will answer questions about their alcohol and substance use; mental and physical health; mood and anxiety; and sleep quality.
Participants will download an app called MetricWire. The app will send 3 sets of questions to be answered at different times throughout the day.
The study visits will include 2 stages:
- Active stage. On these visits, participants will use a virtual reality system called the Meta Quest Pro (MQP) as they choose. Then they may choose among video games, puzzles, books, crafts, and other activities.. These sessions will last for 3 hours.
- Passive stage. On these visits, participants will watch videos selected by the research team. These sessions will last for 3 hours.
On the last visit of each stage, participants will sit in a room that looks like a bar. They will answer questions about their cravings, their urge to drink, and how many drinks they would buy. Participants will be served 1 drink containing alcohol. They will be asked about their cravings and subjective effects of alcohol after drinking it.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Description:
This study will investigate the effects of cognitive and sensorimotor environmental enrichment (EE) on alcohol drinking, alcohol cue-reactivity, and other related outcomes in participants with alcohol use disorder (AUD). The hypothesis is that the psychological and physiological effects of environmental enrichment will confer therapeutic benefits for people with AUD, especially on measures of alcohol consumption and cue-elicited craving.
Objectives:
Primary Objectives:
1. Evaluate the effects of EE on alcohol consumption
Secondary Objectives:
- Evaluate the effects of EE on other ecological momentary assessments (EMA)
- Evaluate the effects of EE on bar-lab assessments
Endpoints:
Primary Endpoints:
1. Self-reported alcohol consumed using ecological momentary assessment
Secondary Endpoints:
- State assessments of varying psychological, social, and environmental domains associated with AUD
- Cue reactivity: AUQ, AAS
- APT
- Alcohol challenge: B-BAES, DEQ-5, AUQ, BrAC
Study Type
Enrollment (Estimated)
Phase
- Phase 1
Contacts and Locations
Study Contact
- Name: Lorenzo Leggio, M.D.
- Phone Number: (240) 478-1503
- Email: lorenzo.leggio@nih.gov
Study Contact Backup
- Name: Ryan E Tyler
- Phone Number: (240) 789-0347
- Email: ryan.tyler@nih.gov
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- Recruiting
- National Institute on Drug Abuse
-
Contact:
- Lorenzo Leggio, M.D.
- Phone Number: 240-478-1503
- Email: lorenzo.leggio@nih.gov
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
- INCLUSION CRITERIA:
To meet eligibility for this study, participants must meet all the following criteria:
- At least 21 years old
- Owns a cellular device ("smart phone") and is willing to download the EMA application and use it to answer the study questionnaires
- Diagnosis of alcohol use disorder (minimum of 2 DSM-5 criteria on a valid diagnostic tool, e.g., Mini-International Neuropsychiatric Interview (MINI) or the Structured Clinical Interview for DSM Disorders (SCID))
- Self-reported drinking, according to alcohol Timeline Follow-Back (TLFB), of > 7 drinks per week for females or > 14 drinks per week for males, on average, during the 28-day period prior to screening + at least four days with > 3 drinks for females or > 4 drinks for males during the 28-day period prior to screening
- Most recent Clinical Institute Withdrawal Assessment for Alcohol - revised (CIWA-Ar) score < 10
- If a female of childbearing potential: not pregnant or breastfeeding, no intention to become pregnant during the study duration, and agrees to use a highly effective contraception method to prevent pregnancy for the entire study duration. Highly effective contraception methods will be determined by the MAI or designee.
EXCLUSION CRITERIA:
Any individual who meets any of the following criteria will be excluded from this study:
- Current use of FDA-approved pharmacotherapy for AUD (or of a medication intended as an off-label use to treat AUD as determined by the MAI), or currently seeking treatment for AUD
- Medical and/or mental health conditions that are clinically unstable and would therefore compromise the safety and/or scientific integrity of the study, as determined by the MAI or study team respectively.
- Known history of clinically significant cybersickness.
- Any other reason or clinical condition that the Investigators judge would interfere with study participation and/or be unsafe for a participant
- Unable to speak, read, write, and understand English
Justification: Many of the assessments have only been validated in English, and therefore, a non-English translation would jeopardize the scientific integrity of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Subject with alcohol use disorder
subjects (Female/ Male) aged 21 and up
|
This study investigates how different environments and activities affect alcohol consumption and related outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the effects of EE on alcohol consumption
Time Frame: 1-3 months for each participant
|
Self-reported alcohol consumed using ecological momentary assessment
|
1-3 months for each participant
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the effects of EE on other EMA assessments
Time Frame: 1-3 months for each participant
|
Real-time, real-world data collection of state variables and alcohol consumption enhances the ecological validity of the data.
This also allows for evaluation of how dynamics in psychological, social and environmental measures are related to changes in alcohol consumption.
|
1-3 months for each participant
|
|
Evaluate the effects of EE on bar-lab assessments
Time Frame: 1-3 months for each participant
|
Alcohol craving (measure here via AUQ) is a key factor and predictor of persistent and heavy alcohol use and is attenuated by some treatments.
AAS measures attention to alcohol cues.
APT serves as a measure of economic demand for alcohol.
The subjective response to alcohol is a predictor of AUD vulnerability and treatment outcomes.
|
1-3 months for each participant
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lorenzo Leggio, M.D., National Institute on Drug Abuse (NIDA)
Publications and helpful links
General Publications
- Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016 Aug;3(8):760-773. doi: 10.1016/S2215-0366(16)00104-8.
- Nicastri CM, McFeeley BM, Simon SS, Ledreux A, Hakansson K, Granholm AC, Mohammed AH, Daffner KR. BDNF mediates improvement in cognitive performance after computerized cognitive training in healthy older adults. Alzheimers Dement (N Y). 2022 Aug 30;8(1):e12337. doi: 10.1002/trc2.12337. eCollection 2022.
- Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006 Sep;7(9):697-709. doi: 10.1038/nrn1970.
- Edwards S, Kenna GA, Swift RM, Leggio L. Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr Pharm Des. 2011;17(14):1323-32. doi: 10.2174/138161211796150765.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10002341
- 002341-DA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
University of Wisconsin, MadisonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingAlcohol Use Disorder | Alcohol Use Disorder (AUD)United States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
Clinical Trials on Evaluate the effects of Environmental Enrichment (EE) on alcohol consumption
-
María Isabel EspinosaBiomedical Research Institute Sols-Morreale (CSIC-UAM); Centro de BiologÃ-a... and other collaboratorsNot yet recruitingInsulin Resistance | Type 2 Diabetes Mellitus with Features of Insulin Resistance
-
Daniela Romero ReyesUniversidad Nacional de Educación a DistanciaCompletedAlcohol; Harmful UseMexico
-
University of CopenhagenBispebjerg HospitalRecruitingBlood Sample | Biotin Ingestion | Interference With Routine Analyical TestsDenmark
-
Fondazione Policlinico Universitario Agostino Gemelli...Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello; Università degli... and other collaboratorsRecruitingMedulloblastoma, ChildhoodItaly
-
Hospital Mutua de TerrassaCompletedInflammatory Bowel Diseases | Hepatitis C Virus InfectionSpain
-
Cukurova UniversityNot yet recruitingStrabismus | Emergence Delirium | Sevoflurane | Low Flow Anesthesia
-
PhotocureCompletedAcne VulgarisUnited States
-
Orexigen Therapeutics, IncCompleted